Riskpilot← Back to searchSign inGet full accessGramtec Studio AB
ABActiveOrg 5594210345Norrgatan 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20231 employees
Revenue 2025
SEK 26K
+44% vs 2024
EBITDA margin
-419.2%
+20% vs 2024
Equity ratio
90.0%
Financial strength
Net profit 2025
SEK 135K
+199% vs 2024
| Revenue | SEK 26K | +44% |
| EBITDA | SEK -109K | +20% |
| Net profit | SEK 135K | +199% |
| Total assets | SEK 209K | +50% |
| Equity | SEK 188K | +255% |
| Employees | 1 | — |
Legal name
Gramtec Studio AB
Org number
5594210345
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7 februari 2023
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultverksamhet inom företagsutveckling, affärsutveckling, marknadsföring, coaching och personlig utveckling och därmed förenlig verksamhet. Bolagets verksamhet avser att bedriva utveckling och försäljning av produkter och tjänster inom hjälpmedelsteknik och ortopedteknik därmed förenlig verksamhet.
Address
Norrgatan 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 18 | 26 |
| Staff expenses | — | — |
| EBITDA | −137 | −109 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −137 | −109 |
| Net financials | — | — |
| Profit before tax | −137 | 136 |
| Tax | −0 | −1 |
| Net profit | −137 | 135 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 139 | 209 |
| Equity | 53 | 188 |
| Long-term debt | 0 | 0 |
| Short-term debt | 86 | 20 |
| Total debt | 86 | 20 |
EBITDA margin
-419.2%
This company
15.8%
Market median
-2753% vs market
20242025
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20242025
Return on equity
71.8%
This company
18.4%
Market median
+290% vs market
20242025
Net profit margin
519.2%
This company
8.1%
Market median
+6310% vs market
20242025
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20242025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20242025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-04-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gramtec Development AB | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gramtec Business Partner Aktiebolag
Gramtec Studio AB Board members of Gramtec Studio AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Erik Gramnaes | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Lisa Sofia Gramnaes | Board of Directors | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |